Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

European Research Council grant · Running

visionPRINT Integrating Quality Monitoring into 3D Bioprinting via Light Sheet Microscopy

Coordinator
University of Galway, Ireland
Runs
1 January 2026 to 30 June 2027
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101248733

What the project is doing

In the project's own words, from its summary on CORDIS.

A critical bottleneck in bioprinting hardware is the lack of integrated quality monitoring features for characterising print accuracy and cellular composition during fabrication. This limitation makes it challenging to develop reproducible and standardised bioprinting protocols, which are essential for GMP-compliant production. The lack of integrated quality monitoring also leads to a reliance on destructive, post-printing analysis methods that are incompatible with clinical translation.

To address this problem, visionPRINT will develop a 3D bioprinting platform with an optical imaging system and complementary use of Light Sheet Fluorescence Microscopy (LSFM). Unlike current bioprinting hardware systems, visionPRINT will provide volumetric quality assessment of bioprinted constructs. visionPRINT will be the first bioprinting system to offer this level of integrated quality control, and this technological differentiation will help facilitate market adoption as the industry progresses toward standardised protocols and clinical applications.visionPRINT’s integrated data-driven quality monitoring features will transform bioprinting workflows across research, development, and clinical applications.

Comprehensive volumetric data logging capturing both construct shape and cell composition will help end users enhance the accuracy and reproducibility of their bioprinting protocols. Furthermore, the technology will make it easier for end-users to standardise protocols and demonstrate GMP-compliant production for regulatory approval. Ultimately, visionPRINT will accelerate the development of safe and functional bioprinted tissues for clinical applications, benefiting patients worldwide.

Topics

Who is involved

OrganisationCityCountryRole
University of GalwayGalwayIrelandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI